Christopher Garris
1.6K posts

Christopher Garris
@csgarrix
Assistant Professor Mass General @MGHCSB @MGHPathology and Harvard Med @harvardmed specializing in Immuno-Oncology with a focus on Dendritic Cells.








Johns Hopkins University has urged the U.S. Office of Management and Budget to reconsider proposed changes to federal research funding rules that could weaken merit-based, expert-driven review and destabilize America's research enterprise. bit.ly/4w1BVLT #ResearchSavesLives





BREAKING: Beloved New Zealand star Sam Neill has sadly passed away at age 78 surrounded by family in Sydney. "The loss was sudden and unexpected but blessed by the fact that Sam remained cancer free." More to come soon.


@LocasaleLab To be clear here, my view is that this is the behavior of a person who has never benefited from having a boss, not the behavior of a distinguished scientist.






@stefan_rucman @LocasaleLab You can search other non profits and see examples of high executive compensation. It boils down to accountability. If there are few external pressures to encourage efficiency, then efficiency won’t happen. If a lawn gets over fertilized, then weeds grow.



The path from foundational biology research to life-saving therapies is often measured in decades. This year, that journey for one Whitehead discovery reached a remarkable milestone 1/4







Lila Sciences may raise about $2 billion at an $8.5 billion valuation. That number looks incredible if you treat Lila as a normal AI biotech. It makes a little more sense (maybe!) if you treat it as a bet on a new R&D operating system. Lila’s pitch is AI Science Factories: AI systems connected to automated labs that generate hypotheses, design experiments, run them, learn from the results, and repeat. In other words: model, robot lab, experiment, data, repeat. The whole shebang. Or “scientific superintelligence” and “operating system for science," as Lila calls it. (3/7)





